Diabetes drug may help prevent aortic rupture
Use of the drug was associated with 40-87% reductions in aneurysm growth in a Queensland observational study of 1700 patients undergoing yearly surveillance for abdominal aortic aneurysms (AAA).
This included 173 patients receiving metformin for diabetes. This group showed signs of slower growth over 1-4 years compared with other patients in the study cohorts.
The findings suggested a